BlackRock Technology and Private Equity Term Trust (BTX) Financials
BTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 1.6 billion | 28.6 million |
| Dec. 31, 2024 | 1.8 billion | 23.6 million |
| Sept. 30, 2024 | 7.7 million | 53.1 million |
| June 30, 2024 | 1.9 billion | 38.8 million |
BTX Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2025 | ? | ? |
| Dec. 31, 2024 | ? | ? |
| Sept. 30, 2024 | -6.3 million | 405000 |
| June 30, 2024 | -2.5 million | 423000 |
BTX Net Income
No data available :(
BTX Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | - | - | - |
| Dec. 31, 2024 | - | - | - |
| Sept. 30, 2024 | 4.3 million | - | - |
| June 30, 2024 | 55908 | - | - |
BTX Shares Outstanding
BTX Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2025 | - | - | - | - |
| Dec. 31, 2024 | - | - | - | - |
| Sept. 30, 2024 | 19000 | 1.0 million | 3.4 million | - |
| June 30, 2024 | 249000 | 987000 | 3.9 million | - |
BTX Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2025 | - | - |
| Dec. 31, 2024 | - | - |
| Sept. 30, 2024 | 487000 | -60000 |
| June 30, 2024 | 47000 | 95000 |
BTX
Price: $9.03
Dividend Yield: 7.19%
Forward Dividend Yield: 6.98%
Dividend Per Share: 0.63 USD
Earnings Per Share: 0.12 USD
P/E Ratio: 54.42
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 2.6 million
Market Capitalization: 1.0 billion
Average Dividend Frequency: 11
Years Paying Dividends: 6
DGR3: 2.21%